hogfan's picks

[pappy]

As you know a lot has happened with wkbt since my last post.

$77.8M revenue with earnings of $31.2M or $1.04 eps is now expected to be reported for 2010.

With the mid-point of expected organic growth for 2011 putting revenue around $109M & eps @$1.45.

In spite this kinda growth the stock has a p/e ratio of 3 & a forward p/e ratio of 2 when one considers that acquisition growth is the other half of planned growth.

With the stock expected to be listed in about 90 days institutions may become interested in a company with this kind of growth & a excellant balance sheet.

A lot of investors have said they don't like Chinese pharm. companies but there's no denying the future growth of this industry.

Besides wkbt nuin is also one of my favorites.

Both should be listed this year & both should continue their outstanding growth & at some point the market should give some recognition to the fine growth these two companies are achieving.